Welcome to 3PBIOVIAN On Air.
At 3PBIOVIAN, we believe that innovation also lies in how we share knowledge. With the help of AI, we’ve transformed our scientists’ original articles into audio, making our research more accessible while preserving the authorship and scientific rigor of our experts.
Here is the first one:
From Research Stage to GMP Production.
An article co-written by our team that reviews how biopharmaceutical GMP production requires strict controls — from cleanrooms to traceable materials and validated processes, all guided by highly qualified talent. These requirements, shaped by past safety failures, make manufacturing more complex but ensure patient protection.
Full transcription:
Welcome to the deep dive.
If you’ve ever taken prescription medicine, you are directly impacted by what we’re talking about today. Definitely, it’s this, well, incredibly challenging, almost invisible journey, really taking a research discovery, something promising, from the lab, exactly, and turning it into a safe, usable biopharmaceutical product. It’s a whole different world.
It really is. And our mission today, for you listening is to get a handle on that huge operational shift, that regulatory change that happens, you know, the moment a project leaves the research lab, the flexible lab, right, and enters clinical manufacturing, which is all governed by GMP Good Manufacturing Practice. You know, I always figured the science part, the discovery was the toughest hurdle. A lot of people do. But looking into this, it seems like the real battle happens in the manufacturing plant. Research loves flexibility, right? Speed, trying new things. Improvisation is key. Sometimes, yeah, if something doesn’t work, you tweak it on the fly. But GMP demands, well, the total opposite, complete opposite, strict standardization, exhaustive quality control. You need to be able to trace everything, every material, every single step taken. It sounds incredibly restrictive, it is, but it’s not built for convenience, you see, frankly, for saving money initially. It’s a whole culture built around preventing disasters.
Okay, that makes sense. But that level of control, that rigor, it must add a huge cost to the final medicine. Oh, absolutely significant costs. So, before we dive into the practical stuff, how things actually change day to day, we need to ask why? Why are these super strict rules legally required? How did we get here? You mentioned it was like the Wild West before it really was and really was. And unfortunately, the rules we have now are, well, they’re written in tragedy. Go back to the early 1900s there was basically zero regulation, none, pretty much. And that meant dangerous products, contaminated injections, things like that, could easily get onto the market.
And wasn’t there that awful story about a horse, Jim? Was it? Ah, yes, Jim the horse, a classic tragic example. Jim was used to produce diphtheria antitoxin, but then he got tetanus. Oh, no, he was put down, but the records, they got mixed up. Somehow. The contaminated serum from Jim wasn’t properly tracked, got mixed with good batches and given to patients, given to children suffering from diphtheria. Several died as a direct result of the tetanus contamination. That’s horrific, it is, and that disaster taught the industry the hard way about documentation. Traceability. You have to know where every single drop came from and where it ended up. No excuses. But even then, the rules didn’t catch up immediately. No, it was slow. Jump forward to 1937 the sulfonylumide disaster. Over 100 people died. What happened there? A chemist used diethylene glycol, it’s basically a toxic solvent like antifreeze, to dissolve the active drug for a cough syrup. Why would they do that? To make it palatable, liquid. But the critical point is, back then, there was no legal requirement to test new drugs for safety before selling them. Unbelievable. That mass poisoning finally spurred some real action in the US, the Federal Food, Drug and Cosmetic Act of 1938 but what’s really chilling, it’s that history repeated itself. 2007 Panama, nearly 400 people dead from contaminated cough syrup. Don’t tell me. The exact same chemical, diethylene glycol, how? in 2007 this time, it was imported, labeled incorrectly as a harmless glycerin substitute by the manufacturer, then mislabeled again by an intermediary in Spain. Wow. And that highlights perfectly why we have cGMP now. The C is for current. Modern rules demand rigorous identity testing for all incoming raw materials. You don’t just trust the label, you test it yourself, period. Okay, so contamination and lack of testing. Oh, what else there’s thalidomide too. Wasn’t there late 50s, exactly. Thalidomide drives home the need for premarket efficacy and safety testing, especially considering different patient groups. It was initially for sleep, right? I remember, but it got used off label for morning sickness in pregnant women. The result was devastating birth defects in well over 10,000 children worldwide. Just off that disaster directly led to the much stricter clinical study rules and regulatory approvals we have today. So you see, it wasn’t one single event. It was this accumulation of tragedies that built the foundations of GMP, led to bodies like the EMA in Europe. And why the rules are constantly being updated, hence current GMP.
Okay, so, the history explains the why, the sheer necessity born from past failures. Now let’s get practical. How does this translate on the ground. What actually changes when a project moves from that flexible research setting into a GMP production suite? What does that look like?
Well, the first thing you’d notice is just the physical space itself. It’s totally different. It’s designed entirely around minimizing contamination, especially from people. People are the biggest source, by far. BMP facility needs clean room conditions, yeah, highly controlled air quality. We’re talking specialized ventilation systems like single pass airflow, meaning the air goes in straight out, no recirculation, exactly. It prevents particles, dust, skin flakes, whatever, from building up in the room. That’s a huge difference from a standard lab and getting into the room, I imagine it’s not just throwing on a lab coat, not even close. In a typical Research Lab, yeah, you grab a coat, open the door, you’re in, yeah. For GMP, entry is through pressured air locks. Yeah, it controls air movement and the gowning. That’s a whole procedure in itself, like what you have to put on specialized, sterilized gear, coveralls, hoods, masks, booties, gloves, sometimes multiple layers of gloves all put on in a specific sequence. Why so much? To contain everything, skin flakes, hair, even fibers from your clothes underneath. The goal is absolute minimal particle shedding. Yeah, if you say accidentally scratch your nose while you’re gowning up, yeah, you often have to start the whole 15 minute process over again, seriously? dead serious. The level of detail is intense, and the personnel need rigorous training on how to move, how to behave in the clean room to minimize creating contamination. Wow. Okay, that sounds intense, but necessary, I guess. What about the stuff you use at the raw materials? Say, I’ve got a chemical that works perfectly in my research, cheap, easy to get. Can I just use that for my clinical batch? Ah, the research grade versus GMP grade question. Big difference. Think of research grade like buying veggies at a market without a label. They might be fine, but you have no verified history. Okay. For clinical production, every single material has to be GMP grade. That means it was manufactured under a certified, audited quality system. There’s documentation for everything. So even something simple, like sodium chloride, basic salt, yep, even that needs a full pedigree, a paper trail showing exactly who made it, when, how, under what controls and the supplier themselves needs to be qualified audited. You have to prove they meet standards. So, not just ordering from the cheapest catalog supplier, absolutely not.
And the control doesn’t stop there. When materials arrive, there are strict procedures for receiving them, quarantining them, testing them to confirm identity and purity, releasing them from quarantine and storing them under controlled conditions, controlled how? Constant monitoring, temperature, humidity, inventory tracking, nothing, absolutely nothing, gets used in manufacturing until the independent quality assurance unit has reviewed all the testing data and formally released that specific batch of material. Kqa is the gatekeeper there. What about the machinery, the equipment? If my lab bioreactor works fine, do I need a special GMP, certified one. That’s a common misconception. Equipment isn’t really GMP certified in itself. It needs to be suitable for its intended purpose, meaning it has to do the job reliably. It must be designed so it can be thoroughly cleaned and sterilized, and it absolutely cannot react with or shed things into the product that would affect its quality. Okay. So, suitability, but what about scaling up? That’s often the killer. Some techniques that work beautifully on a small research scale are just impractical for GMP. Think about Ultra centrifugation, maybe, super fast spinning to separate things, right? Great for tiny volumes in the lab, but try scaling that up to process hundreds of liters. They’re incredibly complex machines, a nightmare to take apart, clean thoroughly enough and then prove that your cleaning method works every single time. So, you might have to just ditch a working method, often, yes, even if it works perfectly in research, if you can’t scale it, clean it and validate reliably for GMP, you have to find a different technology that can mean redesigning a huge part of your process. It’s costly, time consuming, but unavoidable for GMP. That sounds incredibly frustrating for scientists and probably expensive, very, and speaking of costs and process, another huge factor is procedural control. GMP often demands what’s called dedicated manufacturing. What does that mean? In simple terms, usually only one product can be manufactured in a specific room or suite at any given time. Why? To minimize any possible risk of cross contamination between different products. Imagine if trace amounts of product A got into product B. Could be disastrous, right, but that must kill efficiency. It does. It’s a major cost driver. Your expensive, specialized facility might only be actively producing product for a fraction of the day or week because of these segregation requirements, capital costs go way up, and once you figured out your process, your recipe, you’re locked in, completely locked in before you even start making GMP material, every single step of the production process must be defined in writing, in excruciating detail, in documents called batch manufacturing records or similar, every stir speed, every temperature, everything and during production, operators have to follow that document precisely and record everything they do, every measurement they take in real time, no deviations allowed, unless formally investigated and approved. So, note, let’s just add a bit more of the slick in the lab. Absolutely not, in fact, before making the actual clinical batches, companies run several engineering or consistency batches, basically full-scale practice runs to prove the written process works reliably and consistently every single time, only then do they proceed to make material for human use.
Okay, so manufacturing is rigid. What about testing the final product? Is that just as strict, if manufacturing is locked down, analytics are welded shut, yes, just like the production process, the analytical methods used to test the product must be rigorously validated. Validated means? proven through extensive testing that the method accurately and reliably measures what it’s supposed to measure every time these validated methods are documented in standard operating procedures or SOPs and analysts just follow the SOP, no adjustments, None. Zero flexibility. You perform the test exactly as written in the SOP, no improvising or optimizing on the fly, and the product itself has to meet a whole list of predefined quality specifications. These are the critical quality attributes decided upon during development, like what kind of things? things like the concentration, the active drug, its purity, its pH level, osmolality, which is basically the salt balance important for injection, makes sense, but also checks for things you don’t want, like bio burden, the level of any background microbes, and critically, endotoxin, endotoxin, yeah, these are fragments from the cell walls of certain bacteria. Even if the bacteria are dead, these fragments, if injected, can cause a really severe fever response, even shock. So, there are very strict limits for endotoxins in injectable drugs, and if a batch fails, even one of these tests say the pH is slightly off. It’s a failed batch, period, it typically cannot be released for use, it might have to be destroyed or undergo significant investigation to see if it can be salvaged. Which is rare and difficult and, who makes that final call? The manufacturing team.
No, absolutely not. That’s a crucial part of GMP. The Quality Assurance QA department operates completely independently from production, separation of powers, kind of exactly. QA reviews all the Batch Records, all the testing data, ensures everything was done according to procedure and met all specifications. Only if everything checks out, do they issue a formal certificate of analysis, and then, in Europe, for example, a legally designated qualified person gives the final authorization to release the batch. It’s multiple layers of independent checking. Okay. Independent checks are key. Is that the end of it, once it’s released? Not quite, you also need to prove the drug remains stable over time. How long does it last on the shelf, under what conditions the expiry date, right? So, you have to run formal stability studies, you store samples of the drug substance and the final formulated product under specific temperature and humidity conditions, sometimes for years, testing it periodically?, yep, testing it at set time points to see if it still meets all its quality specifications. Yeah. This data determines the approved storage conditions like refrigerate, Do not freeze, and establishes the shelf life, the expiry date printed on the box. It’s all part of the package. So, wrapping this up, what we’ve really described here is this huge, incredibly rigid framework operating under cGMP, Current Good Manufacturing Practice. It’s well, it’s time consuming. It’s hugely resource intensive, definitely, and it strips away almost all flexibility. Everything needs to be documented, pre approved, validated, before you even think about making something, it does. But as the history shows us, this system, this complexity, it’s absolutely necessary. It touches every single aspect, facility, design, personnel training, the materials you buy, the IT systems that track everything, even how you clean the floors. It’s all geared towards one thing, patient safety, patient safety, product quality and ensuring the medicine actually works as intended. The entire industry accepts this complexity, this cost, because, frankly, nobody wants another sulfonylumide disaster. Nobody wants another fallout of mine, tragedy. It’s the price we pay for public trust in medicines, a price built on some hard lessons learned, which leads us to a final thought for you listening at home, considering the immense cost, the inflexibility, the sheer rigor that cGMP demands for making medicine safe. Think about this, what common product in your daily life, something you use or eat or interact with constantly, if it were suddenly stripped of any similar safety regulations, what would cause the most immediate, most widespread disaster? Something to ponder next time you open a medicine bottle.
